acute myeloid leukemia with myelodysplasia-related changes (Cancer)

Search with Google Search with Bing
Information
Disease name
acute myeloid leukemia with myelodysplasia-related changes
Disease ID
DOID:0081092
Description
"An acute myeloid leukemia with at least 20% blasts in the bone marrow or blood and one of the following: a previous history of myelodysplastic syndrome; multilineage dysplasia; or myelodysplastic syndrome-related cytogenetic abnormalities." [url:https\://pubmed.ncbi.nlm.nih.gov/32864703/]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT03330821 Active, not recruiting Phase 1/Phase 2 Pevonedistat, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia April 18, 2018 October 13, 2025
NCT03526926 Completed A Post-Marketing Observational Study of VYXEOS™ October 23, 2018 June 12, 2020
NCT00416598 Completed Phase 2 Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia November 15, 2006 December 1, 2016
NCT06143839 Recruiting VYxeoS Liposomal Italian Observational Study iN the Real Practice December 7, 2023 February 1, 2026
NCT04231851 Recruiting Phase 2 CPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-related Acute Myeloid Leukemia February 19, 2020 September 30, 2025
NCT04269213 Recruiting Phase 2 CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old July 29, 2021 January 29, 2025
NCT02727803 Recruiting Phase 2 Personalized NK Cell Therapy in CBT May 19, 2016 May 31, 2025
Disase is a (Disease Ontology)
DOID:9119
Cross Reference ID (Disease Ontology)
ICDO:9895/3
Cross Reference ID (Disease Ontology)
NCI:C7600
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:128827005
Cross Reference ID (Disease Ontology)
UMLS_CUI:C2825139